Get Your Asthma Under Control
NHALES stands for Natural History of Asthma with Longitudinal Environmental Sampling. Your participation in NHALES Asthma Study will contribute to research on how the environment affects the human body and asthma. Please consider joining today.
An asthma study that provides at no cost treatment, medications and compensation.
Who Can Participate?
- Moderate to severe asthmatics
- Males and females, aged 18-60
- Females should not be pregnant or breastfeeding at the start of the study, but may still participate if they become pregnant during the study
- Nonsmokers that are not exposed to significant amounts of secondhand smoke
- No history of chronic obstructive pulmonary disease, emphysema, cystic fibrosis (CF), pulmonary fibrosis, non-CF bronchiectasis, sarcoidosis, unstable angina, or pulmonary hypertension
- Not allergic to methacholine
- Able to provide your own transportation to clinic visits
What Is Required?
- Receive at no cost treatment and medications for your asthma
- Participation in the study for each participant will last 5 years
- Participants will have approximately 12 study visits over the course of their participation
- Visits include physical exams, lung tests, collecting biological samples, and completing surveys
- Some participants may be asked to undergo a procedure called bronchoscopy, which looks inside the lungs
- For your time and effort, participants that complete all study visits may receive up to $3,035, with those completing a bronchoscopy receiving an additional $375
- Study visits take place at the National Institute of Environmental Health Sciences Clinical Research Unit in Research Triangle Park, North Carolina
Who Is Running the Study?
The study is run by physicians at the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, U.S. Department of Health and Human Services.
Stavros Garantziotis, M.D.
Stavros Garantziotis, M.D. is passionate about finding cures for chronic lung disease like asthma, COPD and pulmonary fibrosis. He believes that if we can understand the mechanism of disease development for every individual patient, we can design intelligent and effective treatment with less side effects. Dr. Garantziotis obtained his medical degree at the Albert-Ludwigs-University in Germany. He trained in Internal Medicine at the Albert Einstein College of Medicine in New York and in Pulmonary and Critical Care Medicine at Duke University Medical Center, where he was a faculty member before joining the NIEHS to direct the Clinical Research Unit.
For More Information About This Study
- Call: 1-855-MYNIEHS (1-855-696-4347)
- Email: firstname.lastname@example.org
- Protocol Number: 15-E-0058
This content is available to use on your website.Please visit NIEHS Syndication to get started.